Please assess the completion status of the following clinical trial:

Trial Title: The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Anorexia Nervosa~* Women, age 30-70 years~* Osteoporosis or history of clinical fractures (spine, wrist, hip or ribs)~Exclusion Criteria:~* Diseases known to affect bone metabolism~* Hyperparathyroidism~* Medications known to affect bone metabolism in last 12 weeks (or bisphosphonate use in last 1 year)~* Pregnant and/or breastfeeding~* Diabetes mellitus~* History of malignancy involving or affecting the bone, any active malignancy, and/or radiation therapy to the bone~* Fractures of a bone other than a finger or toe in last 1 year

- Gender: FEMALE
- Minimum Age: 30 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Teriparatide (Type: ACTIVE_COMPARATOR): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).